N/A
Completed N=30
Trial of Scrambler Therapy or Sham Treatment for Low Back Pain
Source: ClinicalTrials.gov NCT01896687 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Sep 2014
Primary outcomePrimary: Worst Low Back Pain Score — 5.4; 4.9; 3.2; 5.8 units on a scale — p=<0.001
Summary
This pilot study will evaluate Scrambler therapy and Sham treatment on levels of low back pain, pain sensitivity and mRNA expression of pain sensitivity candidate genes.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Worst Low Back Pain Score |
5.4; 4.9; 3.2; 5.8 | <0.001 sig |
Eligibility Criteria
Inclusion Criteria
- be 18-50 years of age
- diagnosed with persistent nonspecific LBP
- comprehend English
Exclusion Criteria
- 50 years of age
- chronic pain at another site or associated with a painful condition
- pregnant or within 3 months post-partum
- implanted drug delivery system
- heart stents or metal implants such as pacemakers, automatic defibrillator, aneurysm clips, vena cave slips, or skull plates
- history of myocardial infarction or ischemic heart disease within the past six months
- history of epilepsy
- skin conditions such as open sores that would prevent proper application of electrodes
Data sourced from ClinicalTrials.gov (NCT01896687). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.